The Canadian study of cardiac transplantation atherosclerosis

Canadian Journal of Cardiology

Volumn 15, Issue 12, 1999, Pages 1337-1344

  Carrier, Michel ^a,i   Rivard, Michèle ^a   Kostuk, William ^b   Latter, David ^c   Daly, Paul ^d   Davies, Ross ^e   Teo, Koon ^f   Gudas, Virginia ^g   Sullivan, John ^h   White, Michel ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF OTTAWA   (Canada)

^f UNIVERSITY OF ALBERTA   (Canada)

^g UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^h DALHOUSIE UNIVERSITY   (Canada)

ⁱ MONTREAL HEART INSTITUTE   (Canada)

Author keywords

Coronary disease; Transplantation

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; CYCLOSPORIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; LOW DENSITY LIPOPROTEIN; LYMPHOCYTE ANTIBODY; OKT 3; PREDNISONE; THYMOCYTE ANTIBODY; TRIACYLGLYCEROL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOMYOPATHY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DOSE RESPONSE; FEMALE; GRAFT REJECTION; HEART DISEASE; HEART TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE;

ADULT; ANTIHYPERTENSIVE AGENTS; ARTERIOSCLEROSIS; ASPIRIN; CARDIOVASCULAR AGENTS; CYCLOSPORINE; CYTOMEGALOVIRUS INFECTIONS; DILTIAZEM; FEMALE; FOLLOW-UP STUDIES; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS;

EID: 0033394070     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Go SZ, Alderman EL, Schroeder JS, Hunt SA, Wiederhold V, Stinson EB. Progressive coronary luminal narrowing after cardiac transplantation. Circulation 1990;82(Suppl 4):IV269-75.
2. Gao SZ, Schroeder JS, Alderman EL, et al. Clinical and laboratory correlates of accelerated coronary artery disease in the cardiac transplant patient. Circulation 1987;76(Suppl 5):V56-61.
3. McGiffin DC, Savumen T, Kirklin JK, et al. Cardiac transplant coronary disease. A multivariate analysis of pretransplant risk factors for disease development and morbid events. J Thorac Cardiovasc Surg 1995;109:1081-9.
4. Schroeder JS, Gao SZ, Alderman EL, et al. A preliminary study of diltiazem in the prevention of coronary artery disease in heart-transplant recipients. N Engl J Med 1993;328:164-70.
5. Kobashiwaga JA, Katznelson S, Laks H, et al. Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med 1995;333:621-7.
6. Wenke K, Meiser B, Thiery J, et al. Simvastatin reduces graft vessel disease and mortality after heart transplantation. A four-year randomized trial. Circulation 1993;96:1398-402.
7. Pflugfelder PW, Huff M, Oskalns R, Rudas L, Kostuk WJ. Cholesterol-lowering therapy after heart transplantation: a 12-month randomized trial. J Heart Lung Transplant 1995;14:613-22.
8. Carrier M, Pelletier GB, Genest J, Cartier R, Leclerc Y, Pelletier LC. Cholesterol-lowering intervention and coronary artery disease after cardiac transplantation. Ann Thorac Surg 1994;57:353-6.
9. Mehra MR, Ventura HO, Smart FW, Stapleton DD. Impact of converting enzyme inhibitors and calcium entry blockers on cardiac allograft vasculopathy: from bench to bedside. J Heart Lung Transplant 1995;14:S246-9.
10. Miller L, Kobashigawa J, Valantine H, et al, for Sandoz/CVIS Investigators. The impact of cyclosporine dose and level on the development and progression of allograft coronary disease. J Heart Lung Transplant 1995;14:S227-34.
11. Labarre CA, Nelson DR, Faulk P. Endothelial activation and development of coronary artery disease in transplanted human hearts. JAMA 1997;278:1169-75.
12. Petrossian GA, Nichols AB, Marboe CC, et al. Relation between survival and development of coronary artery disease and anti-HLA antibodies after cardiac transplantation. Circulation 1989;80(Suppl 3):III122-5.
13. Kobashigawa JA, Miller L, Yeung A, et al, for Sandoz-CVIS Investigators. Does acute rejection correlate with the development of transplant coronary artery disease? A multicenter study using intravascular ultrasound. J Heart Lung Transplant 1995;14:S221-6.
14. Gao SZ, Hunt SA, Alderman EL, Liang D, Yeung AC, Schroeder JS. Relation of donor age and preexisting coronary artery disease on angiography and intracoronary ultrasound to later development of accelerated allograft coronary artery disease. J Am Coll Cardiol 1997;29:623-9.
15. Gao SZ, Hunt SA, Schroeder JS, Alderman EL, Hill IR, Stinson EB. Early development of accelerated graft coronary artery disease: Risk factors and course. J Am Coll Cardiol 1996;28:673-9.
16. Rickenbacher PR, Pinto FJ, Chenzbraun A, et al. Incidence and severity of transplant coronary artery disease early and up to 15 years after transplantation as detected by intravascular ultrasound. J Am Coll Cardiol 1995;25:171-7.
17. Tuzcu EM, DeFranco AC, Goormastic M, et al. Dichotomous pattern of coronary atherosclerosis 1 to 9 years after transplantation: Insights from systematic intravascular ultrasound imaging. J Am Coll Cardiol 1996;27:839-46.
18. Mehra MR, Ventura HO, Chambers R, et al. Predictive model to assess risk for cardiac allograft vasculopathy: an intravascular ultrasound study. J Am Coll Cardiol 1995;26:1537-44.
19. Johnson DE, Alderman EL, Schroeder JS, et al. Transplant coronary artery disease: histopathologic correlations with angiographic morphology. J Am Coll Cardiol 1991;17:449-57.
20. Neill BJO, Pflugfelder PW, Singh NR, Menkis AH, McKenzie FN, Kostuk WJ. Frequency of angiographic detection and quantitative assessment of coronary arterial disease one and three years after cardiac transplantation. Am J Cardiol 1989;63:1221-6.
21. Pflugfelder PW, Boughner DR, Rudas L, Kostuk WJ. Enhanced detection of cardiac allograft arterial disease with intracoronary ultrasonographic imaging. Am Heart J 1993;125:1583-91.